Ligand Pharmaceuticals Incorporated - PE Ratio

The PE Ratio as of June 2026 (TTM) for Ligand Pharmaceuticals Incorporated (LGND) is 35.70

According to Ligand Pharmaceuticals Incorporated’s latest financial reports and current stock price. The company's current PE Ratio is 35.70. This represents a change of 111.87% compared to the average of 16.85 of the last 4 quarters.

Ligand Pharmaceuticals Incorporated (LGND) Historical PE Ratio (quarterly & annually)

How has LGND PE Ratio performed in the past?

The mean historical PE Ratio of Ligand Pharmaceuticals Incorporated over the last ten years is -143.36. The current 35.70 PE Ratio has changed -2590.28% with respect to the historical average. Over the past ten years (40 quarters), LGND's PE Ratio was at its highest in in the September 2022 quarter at 671.50. The PE Ratio was at its lowest in in the June 2022 quarter at -278.30.

Ligand Pharmaceuticals Incorporated (LGND) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ligand Pharmaceuticals Incorporated PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ligand Pharmaceuticals Incorporated (LGND) Average PE Ratio

How has LGND PE Ratio performed in the past?

The current PE Ratio of Ligand Pharmaceuticals Incorporated (LGND) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ligand Pharmaceuticals Incorporated (LGND) PE Ratio vs. Peers

How is LGND’s PE Ratio compared to its peers?

Ligand Pharmaceuticals Incorporated’s PE Ratio is greater than Praxis Precision Medicines, Inc. (-21.08), greater than Belite Bio, Inc (-57.30), greater than Mirum Pharmaceuticals, Inc. (-7.87), greater than ACADIA Pharmaceuticals Inc. (9.70), greater than ADMA Biologics, Inc. (12.04), greater than Soleno Therapeutics, Inc. (27.09), greater than Viking Therapeutics, Inc. (-7.34), greater than Crinetics Pharmaceuticals, Inc. (-6.98), greater than Dyne Therapeutics, Inc. (-6.15), greater than NewAmsterdam Pharma Company N.V. (-16.48),

Build a custom stock screener for Ligand Pharmaceuticals Incorporated (LGND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ligand Pharmaceuticals Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ligand Pharmaceuticals Incorporated (LGND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ligand Pharmaceuticals Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.